Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Translation01:31

Translation

15.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.5K
Translational Regulation01:29

Translational Regulation

92
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
92
tRNA Activation02:26

tRNA Activation

6.9K
6.9K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

12.2K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NNMT and the methylation sink: integrating metabolism, epigenetics and immunity in cancer.

BMC medicine·2026
Same author

Association between frailty status and osteomyelitis: A nested case-control study.

PloS one·2026
Same author

Indium-Mediated Glue-Like Interlayer Enables Stable High-Capacity Flexible Sodium Metal Batteries.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Efficacy of Adding Intravenous Methylprednisolone to Nebulized Budesonide in RSV Pneumonia: Modification by Bacterial Co-Infection - A Retrospective Cohort Study.

Pediatric health, medicine and therapeutics·2026
Same author

Long-term preservation strategy for legume root nodule phenotypes coupled with a comprehensive evaluation method.

BMC plant biology·2026
Same author

Intestinal tuberculosis in a child: a case report.

Frontiers in medicine·2026

Related Experiment Video

Updated: Sep 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

635

Translation Reprogramming Caused by tRNA Modifications Represents a New Therapeutic Target for Cancer Treatment.

Yan Hu1,2, Ziqi Liu2, Hongke Qu2

  • 1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Wiley Interdisciplinary Reviews. RNA
|August 18, 2025
PubMed
Summary

Aberrant transfer RNA (tRNA) modifications disrupt protein synthesis, driving tumor growth. Targeting these modified tRNAs offers a promising new avenue for cancer therapy.

Keywords:
cancer therapeutictRNA modificationtransfer RNAstranslation reprogramming

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.6K

Related Experiment Videos

Last Updated: Sep 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

635
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.6K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Dysregulated protein synthesis, particularly in cancer cells, supports oncogene expression and malignant phenotypes.
  • Transfer RNAs (tRNAs) are crucial for protein synthesis, mediating amino acid transport based on messenger RNA (mRNA) codons.
  • Aberrant translation reprogramming, influenced by tRNAs, is a hallmark of disease progression.

Purpose of the Study:

  • To review the mechanisms linking abnormal tRNA modifications to tumorigenesis via translation reprogramming.
  • To summarize and discuss the clinical potential of targeting tRNA modification-driven translation in cancer therapy.

Main Methods:

  • Review of existing literature on tRNA modifications, translation reprogramming, and cancer.
  • Analysis of how tRNA abundance, cleavage, and decoding ability are affected by modifications.
  • Exploration of clinical strategies targeting aberrant translation in cancer.

Main Results:

  • Abnormal tRNA modifications significantly impact tRNA abundance, cleavage, and mRNA decoding.
  • These alterations in tRNA function contribute to translation reprogramming and promote tumor progression.
  • Specific tRNA modifications are increasingly recognized as drivers of oncogenesis.

Conclusions:

  • Aberrant tRNA modifications are key contributors to cancer development through translation reprogramming.
  • Targeting the excessive translation driven by tRNA modifications presents a viable therapeutic strategy for cancer treatment.
  • Further research into tRNA modification pathways could unveil novel cancer biomarkers and drug targets.